BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

Recruiting now · Not applicable

Conditions studied: Hypertension, Hypertension, Systolic, Hypertension, Essential

In brief

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

Key facts

Study ID
NCT06059638
Run by
Orchestra BioMed, Inc
People needed
500
Starts
2023-12-27
Expected to finish
2029-08-01
Last updated by the study team
2026-07-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.